Strs Ohio Myriad Genetics Inc Transaction History

Strs Ohio

$26.2 Billion
Q3 2025

A detailed history of Strs Ohio transactions in Myriad Genetics Inc stock. As of the latest transaction made, Strs Ohio holds 2,300 shares of MYGN stock, worth $15,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,300

Previous 2,300 -0.0%

Holding current value

$15,433

Previous $12,000 33.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$3.84 - $8.84 $8,832 - $20,332	2,300 New	2,300 $12,000
Q3 2024 Nov 01, 2024	SELL	$23.97 - $28.6 $572,883 - $683,540	-23,900 Reduced 68.88%	10,800 $295,000
Q2 2024 Aug 05, 2024	SELL	$17.98 - $25.47 $39,556 - $56,034	-2,200 Reduced 5.96%	34,700 $848,000
Q1 2024 May 13, 2024	SELL	$17.59 - $23.59 $77,396 - $103,796	-4,400 Reduced 10.65%	36,900 $786,000
Q4 2023 Jan 30, 2024	SELL	$13.91 - $21.32 $80,678 - $123,656	-5,800 Reduced 12.31%	41,300 $790,000

Q3 2023 Oct 26, 2023	BUY	$15.99 - $23.22 $156,702 - $227,556	9,800 Added 26.27%	47,100 $755,000
Q1 2023 Apr 27, 2023	SELL	$15.26 - $23.75 $123,606 - $192,375	-8,100 Reduced 17.84%	37,300 $866,000
Q4 2022 Jan 26, 2023	BUY	$14.51 - $20.99 $27,569 - $39,881	1,900 Added 4.37%	45,400 $658,000
Q3 2022 Oct 27, 2022	SELL	$18.21 - $27.88 $89,229 - $136,612	-4,900 Reduced 10.12%	43,500 $829,000
Q2 2022 Jul 25, 2022	BUY	$16.45 - $25.88 $69,090 - $108,696	4,200 Added 9.5%	48,400 $879,000
Q4 2021 Jan 24, 2022	BUY	$24.13 - $32.63 $125,476 - $169,676	5,200 Added 13.33%	44,200 $1.22 Million
Q3 2021 Oct 22, 2021	SELL	$29.97 - $36.66 $62,937 - $76,986	-2,100 Reduced 5.11%	39,000 $1.26 Million
Q2 2021 Jul 26, 2021	BUY	$25.39 - $32.61 $38,085 - $48,915	1,500 Added 3.79%	41,100 $1.26 Million
Q1 2021 Apr 23, 2021	SELL	$19.92 - $31.6 $223,104 - $353,920	-11,200 Reduced 22.05%	39,600 $1.21 Million
Q4 2020 Jan 25, 2021	SELL	$12.16 - $19.77 $41,344 - $67,218	-3,400 Reduced 6.27%	50,800 $1 Million
Q3 2020 Dec 14, 2020	SELL	$11.25 - $14.75 $14,625 - $19,175	-1,300 Reduced 2.34%	54,200 $706,000
Q2 2020 Jul 23, 2020	BUY	$10.69 - $16.49 $180,661 - $278,681	16,900 Added 43.78%	55,500 $629,000
Q4 2019 Jan 24, 2020	BUY	$20.93 - $35.1 $31,395 - $52,650	1,500 Added 4.04%	38,600 $1.05 Million
Q3 2019 Oct 21, 2019	BUY	$22.08 - $47.08 $86,112 - $183,612	3,900 Added 11.75%	37,100 $1.06 Million
Q2 2019 Jul 25, 2019	BUY	$22.67 - $35.0 $61,209 - $94,500	2,700 Added 8.85%	33,200 $922,000
Q4 2018 Jan 23, 2019	SELL	$27.23 - $45.56 $16,338 - $27,336	-600 Reduced 1.93%	30,500 $886,000
Q3 2018 Oct 19, 2018	SELL	$37.57 - $50.34 $180,336 - $241,632	-4,800 Reduced 13.37%	31,100 $1.43 Million
Q2 2018 Aug 06, 2018	SELL	$27.75 - $40.17 $111,000 - $160,680	-4,000 Reduced 10.03%	35,900 $1.34 Million
Q1 2018 Apr 20, 2018	BUY	$28.83 - $41.01 $89,373 - $127,131	3,100 Added 8.42%	39,900 $1.18 Million
Q4 2017 Jan 23, 2018	BUY	$28.45 - $37.14 $22,760 - $29,712	800 Added 2.22%	36,800 $1.26 Million
Q3 2017 Oct 23, 2017	BUY	$24.01 - $36.2 $864,360 - $1.3 Million	36,000	36,000 $1.3 Million

Others Institutions Holding MYGN

# of Institutions

239

Shares Held

92.2M

Call Options Held

86.1K

Put Options Held

18.9K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $541M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account